124 related articles for article (PubMed ID: 35352646)
1. Metformin has no Significant Anticancer Effect on Patients with Advanced or Unresectable Cancer: A Systematic Review and Meta-analysis.
Gan X; Cao C; He Y; Hu X; Peng X; Su Y
Curr Pharm Des; 2022; 28(16):1351-1358. PubMed ID: 35352646
[TBL] [Abstract][Full Text] [Related]
2. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
3. The addition of metformin to systemic anticancer therapy in advanced or metastatic cancers: a meta-analysis of randomized controlled trials.
Kim HS; Kim JH; Jang HJ; Lee J
Int J Med Sci; 2020; 17(16):2551-2560. PubMed ID: 33029097
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials.
Wen J; Yi Z; Chen Y; Huang J; Mao X; Zhang L; Zeng Y; Cheng Q; Ye W; Liu Z; Liu F; Liu J
BMC Med; 2022 Oct; 20(1):402. PubMed ID: 36280839
[TBL] [Abstract][Full Text] [Related]
5. The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials.
Wu Z; Qu B; Huang X; Song Y; Gao P; Shi J; Zhou C; Wang Z
Ann Transl Med; 2020 Nov; 8(21):1404. PubMed ID: 33313149
[TBL] [Abstract][Full Text] [Related]
6. Metformin and survival of women with breast cancer: A meta-analysis of randomized controlled trials.
Wang Q; Ma X; Long J; Du X; Pan B; Mao H
J Clin Pharm Ther; 2022 Mar; 47(3):263-269. PubMed ID: 34397110
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of metformin for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Zhang J; Wu J; He Q; Liang W; He J
Transl Lung Cancer Res; 2018 Jun; 7(3):389-396. PubMed ID: 30050776
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
9. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis.
Wan G; Sun X; Li F; Wang X; Li C; Li H; Yu X; Cao F
Cell Physiol Biochem; 2018; 49(3):837-847. PubMed ID: 30184547
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
Yao X; Liu H; Xu H
Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791
[TBL] [Abstract][Full Text] [Related]
12. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
13. The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis.
Li X; Li T; Liu Z; Gou S; Wang C
Sci Rep; 2017 Jul; 7(1):5825. PubMed ID: 28724893
[TBL] [Abstract][Full Text] [Related]
14. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
[TBL] [Abstract][Full Text] [Related]
15. Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis.
Xie W; Li T; Yang J; Shang M; Xiao Y; Li Q; Yang J
Oncotarget; 2017 Sep; 8(42):73079-73086. PubMed ID: 29069850
[TBL] [Abstract][Full Text] [Related]
16. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
17. Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.
Guo J; Xu K; An M; Zhao Y
Oncotarget; 2017 Sep; 8(39):66169-66177. PubMed ID: 29029501
[TBL] [Abstract][Full Text] [Related]
18. Metformin Adjunct With Antineoplastic Agents for the Treatment of Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies.
Luo X; Chen X; Wang L; Yang B; Cai S
Front Pharmacol; 2021; 12():639016. PubMed ID: 34149406
[No Abstract] [Full Text] [Related]
19. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
Li J; Huo X; Zhao F; Ren D; Ahmad R; Yuan X; Du F; Zhao J
JAMA Netw Open; 2020 Oct; 3(10):e2020312. PubMed ID: 33048129
[TBL] [Abstract][Full Text] [Related]
20. The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials.
Brancher S; Ribeiro AE; Toporcov TN; Weiderpass E
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2819-2836. PubMed ID: 34264392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
